An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers. - Moran Elishmereni; Yuri Kheifetz; Henrik Søndergaard; Rune Viig Overgaard; Zvia Agur (PLoS Comput. Biol., 2011)